The Cell-Therapy Quality Checklist: Questions About Sourcing, Processing, and Consent

The most important part of a cell-therapy conversation may happen before any procedure is discussed. Quality is not a marketing phrase; it is a set of concrete questions about sourcing, product identity, testing, storage, consent, clinical screening, and follow-up. A patient should be able to understand the answers in plain language.

Ask About the Product, Not Just the Category

A responsible discussion identifies what is being proposed. Ask whether the material is autologous or donor-derived, what screening is performed, how the product is processed, and what testing is done before use. The ISSCR patient guide recommends careful evaluation of the science, ethics, and oversight behind proposed stem-cell interventions. [1]

For U.S. audiences, FDA guidance adds an important reminder: human cell and tissue products may carry risks when quality, safety, purity, or potency have not been adequately reviewed. [2] Requirements differ by jurisdiction, but the underlying patient questions remain relevant anywhere: What is this product? How was it prepared? What documentation supports its quality?

Ten Questions Worth Bringing to a Consultation

• What exactly is the proposed product or procedure?
• What is the cell source, and what screening is performed?
• What laboratory or facility standards apply to processing?
• How are identity, sterility, and viability or potency assessed where relevant?
• What evidence applies to this specific proposed use?
• What are the expected risks, limitations, and alternatives?
• Who determines whether I am an appropriate candidate?
• What does the consent form say about uncertainty and adverse events?
• What post-treatment monitoring is planned?
• Who should I contact if I develop a concern after care?

Informed Consent Is a Conversation

A consent form is not simply paperwork. It should support a clear conversation about the purpose of care, the limits of evidence, potential complications, alternatives, costs, and the plan for follow-up. Patients should have time to read, ask questions, and seek a second opinion when appropriate. Pressure to decide immediately is not a substitute for informed consent.

"A high-quality program does not avoid scrutiny. It explains its standards, documents its process, and treats questions as part of good care."

This checklist is educational, not a substitute for medical or legal advice. Regulatory status and facility requirements vary by country and by the product being considered. Bring these questions to a qualified clinician and ask for information that is specific to your proposed care.